104 related articles for article (PubMed ID: 7594731)
1. Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing of Candida species.
Garcha UK; Brummer E; Stevens DA
J Infect Dis; 1995 Dec; 172(6):1620-3. PubMed ID: 7594731
[TBL] [Abstract][Full Text] [Related]
2. Synergy of human neutrophils with fluconazole in killing Candida species.
Brummer E; Stevens DA
Mycopathologia; 1996; 134(3):115-20. PubMed ID: 8981777
[TBL] [Abstract][Full Text] [Related]
3. Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole.
Natarajan U; Randhawa N; Brummer E; Stevens DA
J Med Microbiol; 1998 Apr; 47(4):359-63. PubMed ID: 9569003
[TBL] [Abstract][Full Text] [Related]
4. Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages.
Baltch AL; Bopp LH; Smith RP; Ritz WJ; Carlyn CJ; Michelsen PB
Diagn Microbiol Infect Dis; 2005 Aug; 52(4):299-304. PubMed ID: 15893901
[TBL] [Abstract][Full Text] [Related]
5. Synergy of fluconazole with macrophages for antifungal activity against Candida albicans.
Garcha UK; Brummer E; Stevens DA
Mycopathologia; 1995-1996; 132(3):123-8. PubMed ID: 8684425
[TBL] [Abstract][Full Text] [Related]
6. Effect of iron on fluconazole activity against Candida albicans in presence of human serum or monocyte-derived macrophages.
Minn Y; Brummer E; Stevens DA
Mycopathologia; 1997; 138(1):29-35. PubMed ID: 9404022
[TBL] [Abstract][Full Text] [Related]
7. Time-Kill Kinetics of Rezafungin (CD101) in Vagina-Simulative Medium for Fluconazole-Susceptible and Fluconazole-Resistant
Locke JB; Almaguer AL; Donatelli JL; Bartizal KF
Infect Dis Obstet Gynecol; 2018; 2018():7040498. PubMed ID: 29681727
[TBL] [Abstract][Full Text] [Related]
8. Role of extended culture time on synergy of fluconazole and human monocyte-derived macrophages in clearing Candida albicans.
Gujral S; Brummer E; Stevens DA
J Infect Dis; 1996 Oct; 174(4):888-90. PubMed ID: 8843238
[TBL] [Abstract][Full Text] [Related]
9. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
10. Antifungal activity of propolis against Candida species isolated from cases of chronic periodontitis.
Siqueira AB; Rodriguez LR; Santos RK; Marinho RR; Abreu S; Peixoto RF; Gurgel BC
Braz Oral Res; 2015; 29():. PubMed ID: 26154370
[TBL] [Abstract][Full Text] [Related]
11. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
Shokri H; Sharifzadeh A
J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
[TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal activity of cassia fistula extracts against fluconazole resistant strains of Candida species from HIV patients.
Sony P; Kalyani M; Jeyakumari D; Kannan I; Sukumar RG
J Mycol Med; 2018 Mar; 28(1):193-200. PubMed ID: 28838629
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.
Tóth Z; Kardos T; Kovács R; Kardos G; Nagy F; Prépost E; Barta Z; Takacs I; Majoros L
Mycopathologia; 2018 Dec; 183(6):905-912. PubMed ID: 30382508
[TBL] [Abstract][Full Text] [Related]
14. Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium.
Moosa MY; Sobel JD; Elhalis H; Du W; Akins RA
Antimicrob Agents Chemother; 2004 Jan; 48(1):161-7. PubMed ID: 14693534
[TBL] [Abstract][Full Text] [Related]
15. Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans.
Baltch AL; Smith RP; Franke MA; Ritz WJ; Michelsen PB; Bopp LH
Antimicrob Agents Chemother; 2001 Jan; 45(1):96-104. PubMed ID: 11120951
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
17. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. by E-test method.
Madhavan P; Jamal F; Chong PP; Ng KP
Trop Biomed; 2010 Aug; 27(2):200-7. PubMed ID: 20962716
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species.
Pfaller MA; Rhomberg PR; Messer SA; Castanheira M
Diagn Microbiol Infect Dis; 2015 Apr; 81(4):259-63. PubMed ID: 25600842
[TBL] [Abstract][Full Text] [Related]
20. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
